These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17716660)

  • 1. Role of ChREBP in hepatic steatosis and insulin resistance.
    Denechaud PD; Dentin R; Girard J; Postic C
    FEBS Lett; 2008 Jan; 582(1):68-73. PubMed ID: 17716660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice.
    Iizuka K; Miller B; Uyeda K
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E358-64. PubMed ID: 16705063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
    Ferré P; Foufelle F
    Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the lipogenic pathway in the development of hepatic steatosis.
    Postic C; Girard J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):643-8. PubMed ID: 19195625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
    Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
    J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.
    Matsusue K; Haluzik M; Lambert G; Yim SH; Gavrilova O; Ward JM; Brewer B; Reitman ML; Gonzalez FJ
    J Clin Invest; 2003 Mar; 111(5):737-47. PubMed ID: 12618528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
    den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ChREBP, a transcriptional regulator of glucose and lipid metabolism.
    Postic C; Dentin R; Denechaud PD; Girard J
    Annu Rev Nutr; 2007; 27():179-92. PubMed ID: 17428181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hepatic lipogenesis in insulin resistance and Type 2 diabetes is associated with AMPK signalling pathway up-regulation in Psammomys obesus.
    Ben Djoudi Ouadda A; Levy E; Ziv E; Lalonde G; Sané AT; Delvin E; Elchebly M
    Biosci Rep; 2009 Jun; 29(5):283-92. PubMed ID: 18842111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP].
    Robichon C; Girard J; Postic C
    Med Sci (Paris); 2008 Oct; 24(10):841-6. PubMed ID: 18950580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMP-activated protein kinase and carbohydrate response element binding protein: a study of two potential regulatory factors in the hepatic lipogenic program of broiler chickens.
    Proszkowiec-Weglarz M; Richards MP; Humphrey BD; Rosebrough RW; McMurtry JP
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Sep; 154(1):68-79. PubMed ID: 19427916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and steatosis in humans.
    Capeau J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis.
    Uyeda K; Repa JJ
    Cell Metab; 2006 Aug; 4(2):107-10. PubMed ID: 16890538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid metabolism in the liver.
    Canbay A; Bechmann L; Gerken G
    Z Gastroenterol; 2007 Jan; 45(1):35-41. PubMed ID: 17236119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.
    Choi SS; Diehl AM
    Curr Opin Lipidol; 2008 Jun; 19(3):295-300. PubMed ID: 18460922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.
    Bricambert J; Miranda J; Benhamed F; Girard J; Postic C; Dentin R
    J Clin Invest; 2010 Dec; 120(12):4316-31. PubMed ID: 21084751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production.
    Grefhorst A; Hoekstra J; Derks TG; Ouwens DM; Baller JF; Havinga R; Havekes LM; Romijn JA; Kuipers F
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G592-8. PubMed ID: 15817811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.